GAMOPHEN Drug Patent Profile
Which patents cover Gamophen, and when can generic versions of Gamophen launch?
Gamophen is a drug marketed by Arbrook and is included in one NDA.
The generic ingredient in GAMOPHEN is hexachlorophene. There is one drug master file entry for this compound. Additional details are available on the hexachlorophene profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GAMOPHEN?
- What are the global sales for GAMOPHEN?
- What is Average Wholesale Price for GAMOPHEN?
Summary for GAMOPHEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 4,188 |
| DailyMed Link: | GAMOPHEN at DailyMed |
US Patents and Regulatory Information for GAMOPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbrook | GAMOPHEN | hexachlorophene | SOAP;TOPICAL | 006270-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
